Is the technology fully baked?
Several years ago there was a review (that I don't have a link to) of GC-MS, e-nose and metabolomics disease detection, and nearly all of them were responding to non-specific markers of inflammation. Making them selective is the main challenge.
Several years ago there was a review (that I don't have a link to) of GC-MS, e-nose and metabolomics disease detection, and nearly all of them were responding to non-specific markers of inflammation. Making them selective is the main challenge.